ESR1 and breast cancer: In this study, we demonstrate that CDK4/6i and radiotherapy led to an RB-dependent increase in both radiosensitization and breast cancer cell death in multiple, nonoverlapping ER+ and TNBC models in vitro (Figure 1) and in vivo (Figure 5).